Rabeprazole Sodium for Anti-Ulcer CAS 117976-90-6
Contact : Mr.Thyen
Email us at zhangyinglong@ycphar.com
Whatsapp : +86 180 3817 6818
Quick Detail
| Product Name | Rabeprazole Sodium |
| Alias | Rabeprazole Sodium;Rabeprazole Sodium Salt |
| CAS | 117976-90-6 |
| MF | C18H20N3NaO3S |
| MW | 381.42 |
| EINECS | 222-630-7 |
| Purity | 99% |
| Appearance | White Powder |
| Melting Point | 140-141°C dec. |
| Certification | ISO 9001, USP, BP |
| Standard | Enterprise Standard |
| Grade | Pharma Grade |
| Package | 25kg/Drum |
| Storage | −20°C |
| Solubility | H2O: soluble10mg/mL (clear solution) |
| Usage | A partially reversible gastric proton pump inhibitor |
| Payment | Bank Transfer, Western Union, Money Gram |
| Delivery | Safe & timely, around 1-3 days after payment |
Description
Rabeprazole is a proton pump inhibitor that suppresses gastric acid production in the stomach. It has several medical uses: the management of conditions that involve excess gastric acid production (e.g. Zollinger-Ellison syndrome), conditions that are worsened by gastric acid (e.g. ulcerations of the gastrointestinal tract), and conditions involving prolonged exposure to gastric acid (e.g. symptomatic gastroesophageal reflux disease).
Rabeprazole's adverse effects tend to be mild but can be serious, including deficiencies in essential nutrients, rare incidences of liver and bone damage, and dangerous rashes. Rabeprazole can theoretically contribute to numerous drug interactions, mediated both through its metabolic properties and its direct effect on acid in the stomach, though its potential for clinically meaningful drug interactions is low.
Use:
Rabeprazole is used for the purposes of gastric acid suppression.This effect is beneficial for the treatment and prevention of conditions in which gastric acid directly worsens symptoms, such as duodenal and gastric ulcers. Acid suppression is also useful when gastric production of acid is increased, including conditions with excess gastric acid secretion (hypersecretory conditions) like Zollinger-Ellison syndrome, multiple endocrine adenomas, and systemic mastocytosis.
Rabeprazole is also useful alongside antibiotic therapy for the treatment of the pathogen Helicobacter pylori, which otherwise thrives in acidic environments.
Thus, rabeprazole is FDA approved for the treatment of symptomatic GERD in adolescents and adults, healing duodenal ulcers in adults, eradication of Helicobacter pylori, and pathologic hypersecretory conditions.
